{"id":1401129,"date":"2026-11-14T23:04:15","date_gmt":"2026-11-14T23:04:15","guid":{"rendered":"https:\/\/www.europesays.com\/de\/1401129\/"},"modified":"2026-11-14T23:04:15","modified_gmt":"2026-11-14T23:04:15","slug":"stratec-biomedical-und-fresenius-vs-glaxosmithkline-und-medigene-kommentierter-kw-46-peer-group-watch-pharma-chemie-biotech-arznei-gesundheit","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/1401129\/","title":{"rendered":"Stratec Biomedical und Fresenius vs. GlaxoSmithKline und Medigene \u2013 kommentierter KW 46 Peer Group Watch Pharma, Chemie, Biotech, Arznei &#038; Gesundheit"},"content":{"rendered":"<p>14.11.2026,<br \/>\n    10610 Zeichen<\/p>\n<p>In der Wochensicht ist vorne: Stratec Biomedical 11,6% vor Fresenius 6,59%, BB Biotech 4,65%, Sanofi 4,61%, Biogen Idec 2,69%, Valneva 2,64%, Bayer 1,69%, Amgen 1,47%, Novartis 0,74%, Merck Co. 0,7%, Merck KGaA 0,57%, Lanxess 0,38%, Gilead Sciences 0,23%, Sartorius 0,17%, Baxter International 0,08%, Linde 0,05%, MorphoSys 0%, Ibu-Tec 0%, BASF -0,02%, Pfizer -1,7%, Roche GS -3,85%, Evotec -6,26%, Epigenomics -6,99%, Paion -11,35%, Medigene -12,5% und GlaxoSmithKline -19,81%.<\/p>\n<p>In der Monatssicht ist vorne: Bayer 28,02% vor Sanofi 23,83%, Evotec 21,36%, Fresenius 19,82%, Stratec Biomedical 18,98%, Sartorius 15,6%, Novartis 12,37%, Amgen 11,85%, Gilead Sciences 11,65%, BB Biotech 10,43%, Biogen Idec 9,18%, Merck KGaA 8,72%, Lanxess 8,5%, BASF 5,54%, Merck Co. 4,07%, Baxter International 3,7%, Pfizer 1,83%, Valneva 1,42%, Linde 1,34%, MorphoSys 0,15%, Ibu-Tec -3,75%, Paion -5,2%, Epigenomics -8,58%, Roche GS -10,47%, Medigene -12,88% und GlaxoSmithKline -14,1%.<\/p>\n<p>Weitere Highlights: <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/stratec_biomedical\" rel=\"nofollow noopener\" target=\"_blank\">Stratec Biomedical<\/a> ist nun 4 Tage im Plus (12,96% Zuwachs von 24,7 auf 27,9), ebenso <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/bayer_ag\" rel=\"nofollow noopener\" target=\"_blank\">Bayer<\/a> 3 Tage im Minus (0,98% Verlust von 57,08 auf 56,52), <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/basf_se_namens_aktien_on\" rel=\"nofollow noopener\" target=\"_blank\">BASF<\/a> 3 Tage im Minus (0,5% Verlust von 54,54 auf 54,27), <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/epigenomics\" rel=\"nofollow noopener\" target=\"_blank\">Epigenomics<\/a> 3 Tage im Minus (5,33% Verlust von 0,45 auf 0,43).<\/p>\n<p>Year-to-date lag per letztem Schlusskurs MorphoSys 99,26% (Vorjahr: 157,38 Prozent) im Plus. Dahinter Bayer 52,72% (Vorjahr: 91,62 Prozent) und Paion 48,75% (Vorjahr: -63,25 Prozent). Epigenomics -68,79% (Vorjahr: -22,71 Prozent) im Minus. Dahinter Evotec -45,58% (Vorjahr: -33,5 Prozent) und Ibu-Tec -35,75% (Vorjahr: 199,4 Prozent).<\/p>\n<p>Am weitesten \u00fcber dem MA200: <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/stratec_biomedical\" rel=\"nofollow noopener\" target=\"_blank\">Stratec Biomedical<\/a> 37,44%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/bayer_ag\" rel=\"nofollow noopener\" target=\"_blank\">Bayer<\/a> 28,16% und <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/amgen\" rel=\"nofollow noopener\" target=\"_blank\">Amgen<\/a> 23,78%.<br \/>Am deutlichsten unter dem MA 200: <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/epigenomics\" rel=\"nofollow noopener\" target=\"_blank\">Epigenomics<\/a> -71,78%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/medigene\" rel=\"nofollow noopener\" target=\"_blank\">Medigene<\/a> -30,37% und <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/evotec_oai_ag\" rel=\"nofollow noopener\" target=\"_blank\">Evotec<\/a> -29,87%.<br \/>Hier der aktuelle ausserb\u00f6rsliche Blick. Vergleicht man die aktuellen Indikationen bei L&amp;S mit dem letzten Schlusskurs, so lag um 08:30 Uhr die <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/baxter_international_inc\" rel=\"nofollow noopener\" target=\"_blank\">Baxter International<\/a>-Aktie am besten: 2,4% Plus. Dahinter <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/biogen_idec\" rel=\"nofollow noopener\" target=\"_blank\">Biogen Idec<\/a> mit +1,73%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/evotec_oai_ag\" rel=\"nofollow noopener\" target=\"_blank\">Evotec<\/a> mit +0,51%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/bb_biotech\" rel=\"nofollow noopener\" target=\"_blank\">BB Biotech<\/a> mit +0,43%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/pfizer_inc\" rel=\"nofollow noopener\" target=\"_blank\">Pfizer<\/a> mit +0,4%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/merck_kgaa\" rel=\"nofollow noopener\" target=\"_blank\">Merck KGaA<\/a> mit +0,4%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/novartis\" rel=\"nofollow noopener\" target=\"_blank\">Novartis<\/a> mit +0,16%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/sanofi\" rel=\"nofollow noopener\" target=\"_blank\">Sanofi<\/a> mit +0,15%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/lanxess_ag\" rel=\"nofollow noopener\" target=\"_blank\">Lanxess<\/a> mit +0,15%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/valneva\" rel=\"nofollow noopener\" target=\"_blank\">Valneva<\/a> mit +0,12%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/bayer_ag\" rel=\"nofollow noopener\" target=\"_blank\">Bayer<\/a> mit +0,12%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/ibu-tec\" rel=\"nofollow noopener\" target=\"_blank\">Ibu-Tec<\/a> mit 0%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/basf_se_namens_aktien_on\" rel=\"nofollow noopener\" target=\"_blank\">BASF<\/a> mit -0,03%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/gilead_sciences\" rel=\"nofollow noopener\" target=\"_blank\">Gilead Sciences<\/a> mit -0,13%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/sartorius\" rel=\"nofollow noopener\" target=\"_blank\">Sartorius<\/a> mit -0,14%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/merck_co_dl-01\" rel=\"nofollow noopener\" target=\"_blank\">Merck Co.<\/a> mit -0,59%, <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/amgen\" rel=\"nofollow noopener\" target=\"_blank\">Amgen<\/a> mit -0,81% und <a class=\"company_link\" href=\"https:\/\/boerse-social.com\/launch\/aktie\/stratec_biomedical\" rel=\"nofollow noopener\" target=\"_blank\">Stratec Biomedical<\/a> mit -1,08%.<\/p>\n<p>Die Durchschnittsperformance ytd der BSN-Group Pharma, Chemie, Biotech, Arznei &amp; Gesundheit ist 11,22% und reiht sich damit auf Platz 11 ein:<\/p>\n<p>1. PCB (Printed Circuit Board Producer &amp; Clients): 53,57% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/compeq_manufacturing_und_shinko_electric_industries_vs_intel_und_semtech_corporation_kommentierter_kw_45_peer_group_watch_pcb_printed_circuit_board_producer_clients\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>2. IT, Elektronik, 3D: 25,37% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/ams-osram_und_dialog_semiconductor_vs_intel_und_3d_systems_kommentierter_kw_45_peer_group_watch_it_elektronik_3d\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>3. MSCI World Biggest 10: 17,36% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/exxon_und_procter_gamble_vs_chevron_und_general_electric_kommentierter_kw_45_peer_group_watch_msci_world_biggest_10\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>4. Rohstoffaktien: 16,52% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/silver_standard_resources_und_royal_dutch_shell_vs_gazprom_und_bp_plc_kommentierter_kw_45_peer_group_watch_rohstoffaktien\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>5. Versicherer: 15,71% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/axa_und_generali_assicuraz_vs_swiss_re_und_munchener_ruck_kommentierter_kw_45_peer_group_watch_versicherer\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>6. \u00d6lindustrie: 15,52% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/noble_corp_plc_und_royal_dutch_shell_vs_lukoil_und_gazprom_kommentierter_kw_45_peer_group_watch_olindustrie_1\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>7. Licht und Beleuchtung: 14,76% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/fagerhult_und_thorpe_vs_cree_und_dialight_kommentierter_kw_45_peer_group_watch_licht_und_beleuchtung\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>8. Stahl: 14,58% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/arcelormittal_und_salzgitter_vs_voestalpine_und_thyssenkrupp_kommentierter_kw_45_peer_group_watch_stahl\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>9. Energie: 13,91% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/verbund_und_evn_vs_ballard_power_systems_und_verbio_kommentierter_kw_45_peer_group_watch_energie\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>10. Deutsche Nebenwerte: 13,18% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/lufthansa_und_stratec_biomedical_vs_rheinmetall_und_suess_microtec_kommentierter_kw_45_peer_group_watch_deutsche_nebenwerte\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>11. Pharma, Chemie, Biotech, Arznei &amp; Gesundheit: 11,22% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/lanxess_und_evotec_vs_glaxosmithkline_und_medigene_kommentierter_kw_45_peer_group_watch_pharma_chemie_biotech_arznei_gesundheit\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>12. Sport: 10,42% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/callaway_golf_und_manchester_united_vs_world_wrestling_entertainment_und_bwin_kommentierter_kw_45_peer_group_watch_sport\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>13. Global Innovation 1000: 9,89% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/ams-osram_und_toyota_motor_corp_vs_intel_und_glaxosmithkline_kommentierter_kw_45_peer_group_watch_global_innovation_1000\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>14. Post: 9,73% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/osterreichische_post_und_postnl_vs_fedex_corp_und_deutsche_post_kommentierter_kw_45_peer_group_watch_post\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>15. Konsumg\u00fcter: 9,33% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/3m_und_henkel_vs_unilever_und_procter_gamble_kommentierter_kw_45_peer_group_watch_konsumguter\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>16. Aluminium: 9,16%<br \/>17. Zykliker \u00d6sterreich: 4,99% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/wienerberger_und_mayr-melnhof_vs_polytec_group_und_rhi_kommentierter_kw_45_peer_group_watch_zykliker_osterreich\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>18. Telekom: 1,91% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/telecom_italia_und_tele_columbus_vs_bt_group_und_o2_kommentierter_kw_45_peer_group_watch_telekom\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>19. Banken: 0,23% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/bnp_paribas_und_banco_santander_vs_sberbank_und_goldman_sachs_kommentierter_kw_45_peer_group_watch_banken\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>20. Runplugged Running Stocks: -1,37%<br \/>21. Immobilien: -1,67% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/leg_immobilien_und_deutsche_wohnen_vs_gagfah_und_athos_immobilien_kommentierter_kw_45_peer_group_watch_immobilien\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>22. Gaming: -4,98% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/bet-at-homecom_und_william_hill_vs_century_und_gvc_holdings_kommentierter_kw_45_peer_group_watch_gaming\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>23. Computer, Software &amp; Internet : -6,52% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/alibaba_group_holding_und_amazon_vs_wirecard_und_nvidia_kommentierter_kw_45_peer_group_watch_computer_software_internet\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>24. Auto, Motor und Zulieferer: -9,27% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/lyft_und_toyota_motor_corp_vs_leoni_und_polytec_group_kommentierter_kw_45_peer_group_watch_auto_motor_und_zulieferer\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>25. Bau &amp; Baustoffe: -11,27% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/heidelbergcement_und_saint_gobain_vs_hochtief_und_strabag_kommentierter_kw_45_peer_group_watch_bau_baustoffe\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><br \/>26. Luftfahrt &amp; Reise: -11,83% <a href=\"https:\/\/boerse-social.com\/2026\/11\/07\/lufthansa_und_fraport_vs_thomas_cook_group_und_air_berlin_kommentierter_kw_45_peer_group_watch_luftfahrt_reise\" rel=\"nofollow noopener\" target=\"_blank\">Show latest Report (07.11.2026)<\/a><\/p>\n<p><a name=\"comments\"\/>Social Trading Kommentare<\/p>\n<p>\n BSN Podcasts\n<\/p>\n<p><a href=\"https:\/\/audio-cd.at\/page\/podcast\/9309\/\" style=\"text-decoration:none;line-height:1px;font-size:14px;color:#333\" wp_automatic_readability=\"5\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n      Christian Drastil: Wiener B\u00f6rse Plausch<br \/>\n      <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/de\/wp-content\/uploads\/2026\/11\/1794678130_216_100.jpeg\" style=\"width:50px; float:left;margin-right:10px;margin-top:2px\"\/><\/p>\n<p style=\"font-size:14px;margin-bottom:0;font-weight:normal;margin-top:6px;line-height:13px\">Drastil &amp; Seltenreich #13: Microsoft-Verdacht, Toiletten-Missionare und ein Bild mit Ernst Nevrivy, das zu einem Bild ohne Ernst Nevrivy wurde\n        <\/p>\n<p>      <\/a><br \/>\n<br clear=\"all\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"14.11.2026, 10610 Zeichen In der Wochensicht ist vorne: Stratec Biomedical 11,6% vor Fresenius 6,59%, BB Biotech 4,65%, Sanofi&hellip;\n","protected":false},"author":2,"featured_media":1401130,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[269027],"tags":[288975,6605,2696,277952,193929,176748,68513,167724,269131,288974,284,269137,25049,83954,286382,113511,54751],"class_list":["post-1401129","post","type-post","status-publish","format-standard","has-post-thumbnail","category-fresenius-se-co-kgaa","tag-amgen","tag-bayer","tag-bb","tag-biogen","tag-biomedical","tag-biotech","tag-co","tag-fresenius","tag-fresenius-se-co-kgaa","tag-idec","tag-in","tag-merck","tag-novartis","tag-sanofi","tag-stratec","tag-valneva","tag-wochensicht"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/117617299454591162","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/1401129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=1401129"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/1401129\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/1401130"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=1401129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=1401129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=1401129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}